BRIEF published on 02/16/2026 at 07:35, 6 months 20 days ago Nicox reçoit un avis favorable de la FDA concernant sa demande d'autorisation de mise sur le marché (NDA) pour le NCX 470. FDA Nicox Traitement Du Glaucome NCX 470 Soumission D'un Accord De Confidentialité
BRIEF published on 02/16/2026 at 07:35, 6 months 20 days ago Nicox prépare une soumission de NDA pour NCX 470 après avis positif de la FDA FDA NDA Nicox NCX 470 Glaucome
BRIEF published on 02/16/2026 at 07:35, 6 months 20 days ago Nicox is preparing an NDA submission for NCX 470 following a positive FDA opinion FDA Glaucoma NDA Nicox NCX 470
PRESS RELEASE published on 02/16/2026 at 07:30, 6 months 20 days ago Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients FDA Nicox NCX 470 Intraocular Pressure Pre-NDA
PRESS RELEASE published on 02/16/2026 at 07:30, 6 months 20 days ago Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470 Nicox annonce une réunion pré-NDA positive avec la FDA américaine pour NCX 470, confirmant le dépôt de la NDA pour l'été 2026. Collaboration avec Kowa et avancée vers l'autorisation de mise sur le marché FDA Nicox NCX 470 Réunion Pré-NDA Autorisation De Marché
BRIEF published on 02/12/2026 at 07:35, 6 months 24 days ago Nicox maintient son statut PEA-PME pour 2026 PEA-PME Euronext Growth Paris Investissement Ophtalmologie Nicox
BRIEF published on 02/12/2026 at 07:35, 6 months 24 days ago Nicox maintains its PEA-PME status for 2026 PEA-PME Euronext Growth Paris Investment Ophthalmology Nicox
PRESS RELEASE published on 02/12/2026 at 07:30, 6 months 24 days ago Nicox confirme son éligibilité au PEA-PME Nicox confirme son éligibilité au PEA-PME pour l'année à venir, permettant aux investisseurs de continuer à intégrer ses actions dans les comptes PEA PME PEA-PME Investissement Fiscalité Ophtalmologie Nicox
BRIEF published on 02/10/2026 at 07:35, 6 months 26 days ago Nicox to Present Key Data at AGS Annual Meeting 2026 Clinical Trials Glaucoma Nicox NCX 470 AGS 2026
BRIEF published on 02/10/2026 at 07:35, 6 months 26 days ago Nicox présentera des données clés lors de la réunion annuelle de l'AGS en 2026. Essais Cliniques Nicox NCX 470 Glaucome AGS 2026
Published on 09/09/2026 at 00:35, 2 hours 50 minutes ago Troubadour Resources Announces Non-Brokered Unit Private Placement and Convertible Debenture Financing
Published on 09/09/2026 at 00:25, 3 hours ago Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
Published on 09/08/2026 at 23:35, 3 hours 50 minutes ago The Western Investment Company of Canada Limited Announces Intention to Commence Normal Course Issuer Bid
Published on 09/08/2026 at 22:30, 4 hours 55 minutes ago Grid Metals Announces Positive Mineralogical Results at Falcon West, Engages SGS Canada for Ore Sorting Test Work, and Announces Investor Relations Agreements
Published on 09/08/2026 at 22:15, 5 hours 10 minutes ago GameSquare Regains Compliance with Nasdaq's Minimum Bid Price Requirement
Published on 09/08/2026 at 22:50, 4 hours 34 minutes ago Cataneo Set to Unveil the Future of AI Engagement at IBC2026 in Amsterdam
Published on 09/08/2026 at 22:05, 5 hours 19 minutes ago oneworld Partners with Popular App Timeshifter to Help Round the World Travellers Beat Jet Lag
Published on 09/08/2026 at 18:30, 8 hours 55 minutes ago Avolta extends long-term travel retail contracts across four Mexican airports
Published on 09/08/2026 at 17:45, 9 hours 40 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 août 2026
Published on 09/08/2026 at 17:45, 9 hours 40 minutes ago Chiffre d’affaires semestriel consolidé 2026 : 71,8 M€
Published on 09/08/2026 at 17:45, 9 hours 40 minutes ago Damartex / Résultats de l'exercice 2025-2026
Published on 09/08/2026 at 11:00, 16 hours 25 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 11:00, 16 hours 25 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
